https://www.selleckchem.com/pr....oducts/z-vad(oh)-fmk
In age groups 0-4, 50-64, and≥18years, the overall PM incidence was reduced by 64%, 34% and 19%, respectively. In adults≥65years of age, a 69% reduction in PCV10 serotypes was offset by 157% (56%-342%) increase in non-PCV10 serotypes. The overall PM-related mortality rate decreased by 42% (95%CI 4%-65%). Overall case fatality proportion (CFP) was 16% in pre-PCV10 period and 12% in PCV10 period (p=0.41); among persons 50-64years the CFP decreased from 25% to 10% (p=0.04). We observed substantial impact and herd protection for vacci
Like
Comment
Share
